Prestige Prodigy

EQUINE RHINOPNEUMONITIS VACCINE, KILLED VIRUS

An inactivated, concentrated, adjuvanted, tissue culture origin equine herpesvirus type 1 (EHV-1) vaccine.

Prestige Prodigy Indications

This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against abortion and respiratory disease caused by EHV-1. Duration of Immunity has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov.

DOSE: For pregnant mares administer a 2 mL dose intramuscularly in the 5th, 7th and 9th months of pregnancy. Three doses are essential for primary immunization. Maiden and barren mares housed or pastured with pregnant mares should be vaccinated on the same schedule. For primary vaccination against respiratory disease administer three 2 mL doses intramuscularly at 4 to 6 week intervals. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For advice on revaccination frequency, consult your veterinarian.

CAUTIONS: Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. Local reaction may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactic reactions may occur. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103, USA

VLN 165A/PCN 1525.21

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047537.1